Why they’re vital in times of COVID-19

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

More To Explore

Uncategorized

GVS acquires 100% of the Shanghai Transfusion Technology Co., Ltd

GVS announced that it has entered into a binding agreement with Ningbo Fuji Medical Technology Co., Ltd., a company controlled by Shanghai Fosun Pharmaceutical (Group) Co., Ltd., to acquire the entire share capital of Shanghai Transfusion Technology Co., Ltd., a Shanghai headquartered company active in the production and sale of blood management related products. The

Uncategorized

GVS acquires 100% of the Italian Group Haemotronic

GVS has acquired the 100% of the share capital of the Italian Group Haemotronic, a leading supplier of advanced filtration solutions for highly critical applications and a specialized producer of components and bags for the medical sector with plants in Italy and Mexico.  In line with its strategy, the acquisition of the company contributes to

en_USEN
Scroll to Top

Want to explore the global website?

You are currently at GVS Malaysia website. To visit the global website, click the button below.